Novel Mono-Lipidated Dimeric Glucagon-Like Peptide-1 Receptor Agonist With Improved Long-Acting and Hypoglycemic Activity

RSC Advances - United Kingdom
doi 10.1039/c9ra00833k
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2015English

Preparation and Pharmaceutical Characterizations of Lipidated Dimeric Xenopus Glucagon-Like Peptide1 Conjugates

English

Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2020English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons Against Oxidative Insult

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2019English

Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Gastroenterology
HepatologyGastroenterology
2019English

The Key Role of a Glucagon-Like Peptide-1 Receptor Agonist in Body Fat Redistribution

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Molecular and Cellular Mechanisms of Glucagon-Like Peptide-1 Receptor Agonist-Mediated Attenuation of Cardiac Fibrosis

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2015English

Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Science-Business eXchange
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy